Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | THRA | P10827 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30432172 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL9505410 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL29626147 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL8444310 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL8052297 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL941553 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL173283 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL145217 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL93801 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG | |
| SCHEMBL3762716 | 0.98 | THRA (0.58) | ALOX5PTGS2THRATHRBLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 647 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119118176-A | Phosphogypsum purification method used in wet-process phosphoric acid production process | 宜都兴发化工有限公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2024059596-A1 | FORMALDEHYDE-FREE MINERAL WOOL GROWING MEDIA | OWENS CORNING INTELLECTUAL CAPITAL, LLC (US) | 2024-03-21 | — | — | WO | claimed |
| US-20240084101-A1 | FORMALDEHYDE-FREE MINERAL WOOL GROWING MEDIA | OWENS CORNING INTELLECTUAL CAPITAL, LLC | 2024-03-14 | — | — | US | claimed |
| WO-2023180932-A1 | AGRICULTURAL COMPOSITION | ORO AGRI EUROPE, S.A. (PT) | 2023-09-28 | — | — | WO | claimed |
| CN-109644996-B | Suspending agent composition containing validamycin A and hexaconazole | 上海惠光环境科技有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-113604176-A | Acrylic pressure-sensitive adhesive emulsion and application thereof | 江苏晶华新材料科技有限公司 | 2021-11-05 | — | — | CN | claimed |
| EP-3107390-B1 | A METHOD FOR PRODUCING AN AQUEOUS CO-FORMULATION OF METALAXYL | BASF SE (DE) | 2021-07-21 | — | — | EP | claimed |
| EP-3468362-B1 | EMULSIFIABLE CONCENTRATE OF TEFLUTHRIN | SYNGENTA PARTICIPATIONS AG (CH) | 2021-03-10 | — | — | EP | claimed |
| CN-106028812-B | Process for the preparation of an aqueous coformulation of metalaxyl | 巴斯夫欧洲公司 | 2020-06-12 | — | — | CN | claimed |
| EP-3609963-A1 | A UNIVERSAL COLOURING COMPOSITION | Tikkurila Oy (FI) | 2020-02-19 | — | — | EP | claimed |
| US-20170086457-A1 | METHOD FOR PRODUCING AN AQUEOUS CO-FORMULATION OF METALAXYL | BASF SE (DE) | 2017-03-30 | — | — | US | claimed |
| EP-3107390-A1 | A METHOD FOR PRODUCING AN AQUEOUS CO-FORMULATION OF METALAXYL | BASF SE (DE) | 2016-12-28 | — | — | EP | claimed |
| EP-2744833-B1 | INHIBITOR COMPOSITIONS AND METHODS OF USE | NUFARM UK LTD (GB) | 2016-09-28 | — | — | EP | claimed |
| WO-2015124661-A1 | A METHOD FOR PRODUCING AN AQUEOUS CO-FORMULATION OF METALAXYL | BASF SE (DE) | 2015-08-27 | — | — | WO | claimed |
| US-20140194559-A1 | Novel Inhibitor Compositions and Methods of Use | NUFARM UK LIMITED (GB) | 2014-07-10 | — | — | US | claimed |
| EP-2744833-A1 | NOVEL INHIBITOR COMPOSITIONS AND METHODS OF USE | Nufarm UK Limited (GB) | 2014-06-25 | — | — | EP | claimed |
| WO-2013027042-A1 | NOVEL INHIBITOR COMPOSITIONS AND METHODS OF USE | NUFARM UK LIMITED (GB) | 2013-02-28 | — | — | WO | claimed |
| US-20050019655-A1 | An anode of sulfur as active material and ionic liquid electrolyte, e.g. trimethylpropylammonium bistrifluoromethylsulfonimide and lithium bistrifluoromethylsulfonimide; high energy density for portable electronics | SANYO ELECTRIC CO., LTD. (JP) | 2005-01-27 | — | — | US | claimed |
| WO-2001036363-A1 | PROCESS FOR PREPARING ACYLAROMATIC COMPOUNDS | CATALYTICA PHARMACEUTICALS, INC. (US) | 2001-05-25 | — | — | WO | claimed |
| EP-0079635-B1 | ARYLPHENYL ETHERS HAVING HERBICIDAL ACTIVITY | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1986-05-21 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140194559-A1 | Novel Inhibitor Compositions and Methods of Use | NQO1, NQO2, ABCG2 | ALOX5 16/4885PTGS2 271/4885THRA 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.